Ares Capital: Rock-Solid Despite Recession Fears Heading Into Q3 Earnings (NASDAQ:ARCC)
By Press Room
3 Mins read
Ares Capital (NASDAQ:ARCC) is a leading business development company or BDC. Its market cap of $10.5B gives it a significant scale and…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Switzerland’s rightwing…
Microsoft, Boeing, Amazon, Chipotle, Meta, Alphabet, and More Stocks to Watch This Week
By Press Room
2 Mins read
It will be the busiest week of the third-quarter earnings season, with nearly a third of S&P 500 companies scheduled to report. Economists and…
By Ben Glickman Great Ajax Corp. said it wouldn’t be acquired by Ellington Financial after the two real-estate investment trusts agreed to…
Barloworld's stock price influenced by substantial institutional ownership
By Press Room
1 Mins read
© Reuters. Barloworld Limited’s stock price has shown a significant correlation to its substantial institutional ownership. The company’s three majority stakeholders, Zahid…
SINGAPORE (Reuters) – China announced on Friday that it will require export permits for certain graphite products to protect national security, its…
Is It Too Late to Buy Solana? SOL Price Climbs 17% as Interest in New Crypto Casino Grows – What Does it Do?
By Press Room
4 Mins read
Solana (SOL) has climbed an impressive +17% overnight in a strong bounce off 20DMA support, but with SOL trading high – is…
United Therapeutics: Fundamental And Technical Analyses Justify A Buy Decision (UTHR)
By Press Room
7 Mins read
Investment Thesis United Therapeutics Corporation (NASDAQ:UTHR) has been in a long-term uptrend since 2019, making higher highs and higher lows. The stock…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Hana Abu…
Don’t miss these top money and investing features: Sign up here to get MarketWatch’s best mutual funds and ETF stories emailed to you…